Juno Biomedical | Evaluate

January 04, 2018

JP Morgan preview – Clues on CAR-T uptake and oncology timings

Novartis’s CAR speeds towards approval with panel nod

December 01, 2016

Triple meeting – Bluebird upstages its Ash rivals

June 22, 2016

First human Crispr trial is a go, but don’t ask about the IP